학술논문
Safety and immunogenicity of AGS-v PLUS, a mosquito saliva peptide vaccine against arboviral diseases: A randomized, double-blind, placebo-controlled Phase 1 trial
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
23523964